Trial of Community Health Worker-led Decision Coaching
Randomized Trial of Community Health Worker-led Decision Coaching to Promote Shared Decision Making for Prostate Cancer Screening Among Black Male Patients and Their Providers
2 other identifiers
interventional
162
1 country
1
Brief Summary
Black men are disproportionately affected by prostate cancer, the most common non-cutaneous malignancy among men in the U.S. This randomized trial will evaluate the efficacy of a Community Health Worker-led decision coaching program to facilitate Shared Decision Making (SDM) and Prostate Specific Antigen (PSA) screening among Black men with regards to decision quality, the decision making process, patient-provider communication and PSA utilization for Black men in the primary care setting.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable prostate-cancer
Started Oct 2019
Typical duration for not_applicable prostate-cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 7, 2018
CompletedFirst Posted
Study publicly available on registry
October 31, 2018
CompletedStudy Start
First participant enrolled
October 15, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 21, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
September 20, 2023
CompletedResults Posted
Study results publicly available
May 23, 2024
CompletedMay 23, 2024
May 1, 2024
3.5 years
September 7, 2018
March 29, 2024
May 22, 2024
Conditions
Outcome Measures
Primary Outcomes (4)
Prostate Specific Antigen (PSA) Screening Rates
Percentage of participants who receive at least one PSA screening. Screening data are collected through patient self-reports and electronic health record data.
Up to Month 3
Patient Knowledge Survey Score
The Patient Knowledge Survey comprises 12 items assessing participants' understanding of PSA testing and prostate cancer. Respondents provide an answer of "True," "Unsure," or "False." The total score is the sum of correct responses and ranges from 0-12; higher scores indicate greater knowledge.
Day 1
Decision Quality Score
Scale consists of 12 items assessing participants' attitudes toward prostate cancer treatment and screening (6 Pros and 6 Cons of testing) scored on a 5 point Likert scale (Strongly Disagree to Strongly Agree). The total score is the sum of responses and ranges from -24 to +24; Positive scores indicate a more favorable assessment of the pros versus the cons of the test.This survey will be administered twice: once directly following the coaching session prior to the patient's appointment, and again following the appointment.
Day 1
Percentage of Participants Who Make Informed Choice
Percentage of participants who made an Informed Choice to either undergo or decline PSA testing. Informed choices are those in which: 1\. Men with good knowledge and positive measure of informed choice attitudes (\> or = 22) choose to undergo the test OR 2) Men with good knowledge but negative measure of informed choice attitudes (\<22) towards the test, do not undergo the test The Measure of Informed Choice Attitudes survey is administered twice: once directly following the coaching session prior to the patient's appointment, and again following the appointment and the patient's screening decision is recorded during post-appointment.
Day 1
Secondary Outcomes (6)
Decision Self-Efficacy Scale Score
Day 1
Doctor-Patient Communication Survey Score
Day 1
Perceived Efficacy in Patient-Physician Interactions Questionnaire (PEPPI) Score
Day 1
Change in Decisional Conflict Scale Score
Day 1
Satisfaction With Decision Scale Score
Day 1
- +1 more secondary outcomes
Study Arms (2)
Intervention Group
EXPERIMENTALA decision aid along with decision coaching on PSA screening from a Community Health Worker (CHW). The intervention will be administered directly prior to the participant's appointment with their provider.
Control Group
ACTIVE COMPARATORA decision aid along with CHW interaction on dietary and lifestyle modification to serve as an attention control. The intervention will be administered directly prior to the participant's appointment with their provider.
Interventions
counseling from extensively trained CHW
coaching using an educational tool focused on dietary and lifestyle modification
Eligibility Criteria
You may qualify if:
- Patients:
- Black
- Male
- Attending FQHC for routine primary care appointment
- Providers:
- Provider at Sunset Park Health Council Federally Qualified Health Center (FQHC)
You may not qualify if:
- Provider at Sunset Park Health Council Federally Qualified Health Center (FQHC)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
New York University School of Medicine
New York, New York, 10016, United States
Related Publications (1)
Makarov DV, Feuer Z, Ciprut S, Lopez NM, Fagerlin A, Shedlin M, Gold HT, Li H, Lynch G, Warren R, Ubel P, Ravenell JE. Randomized trial of community health worker-led decision coaching to promote shared decision-making for prostate cancer screening among Black male patients and their providers. Trials. 2021 Feb 10;22(1):128. doi: 10.1186/s13063-021-05064-4.
PMID: 33568208DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Danil Makarov
- Organization
- NYU Langone Health
Study Officials
- PRINCIPAL INVESTIGATOR
Danil Makarov, MD
NYU Langone Health
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- CARE PROVIDER, INVESTIGATOR
- Purpose
- SCREENING
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 7, 2018
First Posted
October 31, 2018
Study Start
October 15, 2019
Primary Completion
April 21, 2023
Study Completion
September 20, 2023
Last Updated
May 23, 2024
Results First Posted
May 23, 2024
Record last verified: 2024-05
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- Immediately following publication. No end date.
- Access Criteria
- Proposals may be submitted up to 36 months following article publication. After 36 months the data will be available in our University's data warehouse but without investigator support other than deposited metadata. Information regarding submitting requests and accessing data may be found at (Link to be provided).Researchers who provide a methodologically sound proposal will have access to the data.
Aggregate participant data that underlie the results reported in this article, after de-identification (text, tables, figures, and appendices).